Trialing precision medicine for type 2 diabetes.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 36737670.
- Also identified by DOI 10.1038/s41591-022-02168-5 and PMC identifier 13285963.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A study prospectively evaluating a stratified approach to selecting treatment heralds a new era of precision medicine for type 2 diabetes, which should incorporate ongoing discovery, social determinants of health and healthcare transformation.
Medical subject headings
- Diabetes Mellitus, Type 2